RxDoctor Payments Data

Timothy Oldani

Foot & Ankle Surgery · Saint Louis, MONPI 1225143480

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Convatec Inc. at 50.8% of the total. Reporting peaked in 2023 at $8,171 and has fallen 98.9% since, to $90 in 2025.

$17,946in general payments, 2019–2025

Across 68 payments — averaging $263.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$9K
  • Triad Life Sciences Inc.$7K
  • Stryker$380
  • Smith+Nephew$230
  • Angiodynamics, Inc.$118
  • Organogenesis Inc.$97
  • plus $558 from 16 others

What the payments were for

  • Consulting fees$9,15051%
  • Speaking & faculty fees$4,40025%
  • Travel & lodging$2,37913%
  • Food & beverage$2,01711%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,946 in reported general payments places this provider in the 80th percentile of 163 foot & ankle surgery providers in Missouri.

See all foot & ankle surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$569,750
Medicare patients
377
Services billed
2,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate63$2,311
Tavaborole12$1,950
Ciclopirox44$1,456
Gabapentin113$1,105
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen70$528
Mupirocin78$505
Doxycycline Hyclate53$461
Pregabalin24$413
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip29$382
Ketoconazole18$345
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav48$323
Methylprednisolone35$231
Celecoxib12$128
Clindamycin Hcl22$101
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$97

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →